Crawford Resigns; NCI Director Von Eschenbach Named To Top FDA Spot
This article was originally published in The Pink Sheet Daily
Executive Summary
Von Eschenbach appointed to be acting FDA commissioner following the Sept. 23 resignation of Lester Crawford.
You may also be interested in...
Sweeping Changes At CDER Recommended In IoM Drug Safety Report
Among solutions suggested is six-year fixed term for the FDA commissioner and appointment of external advisory board to oversee cultural changes.
Sweeping Changes At CDER Recommended In IoM Drug Safety Report
Among solutions suggested is six-year fixed term for the FDA commissioner and appointment of external advisory board to oversee cultural changes.
No Double Duty For Von Eschenbach; Niederhuber To Run NCI
John Niederhuber, recently tapped to be NCI deputy director for translational and clinical sciences, will assume the position of chief operating officer, handling day-to-day management of the cancer institute.